Pioneering cancer researcher Frank McCormick, president-elect of the American Association of Cancer Research (AACR), is the 2012 speaker for UC Irvine’s Chao Family Comprehensive Cancer Center’s 14th annual lectureship series.

McCormick, director of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, will discuss “The Future Prospects of Curing Cancer” on Feb. 22, the first of two talks for the annual Allen and Lee-Hwa Chao Lectureship in Cancer Research. “Cancer Therapy Based on the Ras Pathway” is the topic of his second talk on Feb. 23.

The annual lectureship series on cancer research was established in honor of Hsi-Hsiung Chao, a UC Irvine benefactor who died in 1999 and the father of Allen Chao, who along with his siblings are also major donors.

The series aspires to enhance perspectives on cancer for clinicians, faculty, researchers, students and the community at large through interesting and thought-provoking lectures by world renowned leaders in the field of cancer.

McCormick, PhD, FRS, an internationally renowned molecular biologist, is a leading expert on the Ras signaling pathway, which plays a central role in many cancers. He founded the biotech firm Onyx Pharmaceuticals in 1992 and developed the drug Nexavar, which is still used to treat advanced renal cell cancer.

McCormick has led the UCSF cancer center program since 1998. He also holds UCSF’s E. Dixon Heise Distinguished Professorship in Oncology and the David A. Wood Distinguished Professorship of Tumor Biology and Cancer Research.

The lectureship schedule is as follows:

Due to unforseen cirmstances, this event has been postponed.  We will post the new dates once it has been rescheduled.
 
View directions »